Product Information
CLOBAZAM 20 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.4793 per EA under NDC 67877066601. Its NADAC has been published 304 times since Sep 2, 2020.
Strength
20 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877066601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLOBAZAMApproval Type
Generic (ANDA)
FDA Application
ANDA212714On Market Since
9/7/2019
Pharmacological Classes
Price Statistics
The NADAC for CLOBAZAM 20 MG TABLET has been published 304 times since Sep 2, 2020, and over the history we have for it it has declined 51.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4793 per EA |
|---|---|
| All-time high | $1.0933 (Jan 13, 2021) |
| All-time low | $0.4061 (Jul 23, 2025) |
| 52-week high | $0.5144 |
| 52-week low | $0.4061 |
| Median price | $0.6263 |
| Average price | $0.6401 |
| Largest weekly change | +78.0% (Aug 23, 2023) |
| Weeks tracked | 304 |
| Tracking since | Sep 2, 2020 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLOBAZAM 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOBAZAM 20 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.4793 per EA (NDC 67877066601), effective Jun 24, 2026.
How has the price of CLOBAZAM 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOBAZAM 20 MG TABLET has declined 51.7%. It has been tracked across 304 weekly CMS publications since Sep 2, 2020.
What are the highest and lowest recorded NADAC prices for CLOBAZAM 20 MG TABLET?
Since Sep 2, 2020, the NADAC for CLOBAZAM 20 MG TABLET has ranged from a low of $0.4061 (Jul 23, 2025) to a high of $1.0933 (Jan 13, 2021), with a median of $0.6263 per EA.
Are there cheaper alternatives to CLOBAZAM 20 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as CLOBAZAM 20 MG TABLET, but none are currently priced below it.
Who manufactures CLOBAZAM 20 MG TABLET?
CLOBAZAM 20 MG TABLET (NDC 67877066601) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification